- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07421765
Interaction Between Atypical Work Schedules and/or Idel Time at Work on At-risk Gambling Practices (PRAT-JEU)
February 17, 2026 updated by: Centre Hospitalier Universitaire de Nīmes
Evaluation de l'Interaction Entre Les Horaires Atypiques et/ou Les Temps d'inactivité Sur Les Pratiques de Jeu à Risque Chez Les Adultes Travaillant Dans Ces Conditions
At-risk gambling causes individual and social harm, influenced by environmental, psychological, and socioeconomic factors.
In France, 5% of adult gamblers show at-risk gambling practices.
Atypical work schedules and idle time at work could increase this risk, but few studies have explored this.
These working conditions impact the mental and cognitive health of workers, potentially contributing to at-risk gambling, especially during periods of idle time The study authors wish to explore the links between atypical work schedules, idle time at work, and at-risk gambling practices, considering social norms and individual vulnerabilities.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
25
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Amandine Luquiens
- Phone Number: 04.66.68.69.98
- Email: amandine.luquiens@chu-nimes.fr
Study Locations
-
-
-
Nantes, France
- Not yet recruiting
- CHU de Nantes
-
Contact:
- Marie GRALL-BRONNEC
- Phone Number: 02.40.20.66.40
- Email: marie.bronnec@chu-nantes.fr
-
Nîmes, France
- Recruiting
- CHU de Nîmes
-
Contact:
- Anissa Megzarri
- Phone Number: 04.66.68.42.36
- Email: drc@chu-nimes.fr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients will be screened on an ongoing basis from the active caseload of the addiction services at the University Hospitals of Nantes and Nîmes, and information about the study will be disseminated on social media.
Description
Inclusion Criteria:
- Living with current or remission gambling, as assessed using the Problem Gambling Index Scale (PGSI) score of ≥5
- Having been employed during the current year
- Patients with a personal mobile phone number and email address who agree to share them for research
Exclusion Criteria:
- Patient in an exclusion period determined by another study
- Patient who has expressed their opposition to participating in this research
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
People with gambling disorder
|
After having completed a consent form and online self-questionnaires, participants will take part in online interviews lasting 45 to 60 minutes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Identify the predominant lexical classes in participants' discourse
Time Frame: Day 0
|
Hierarchical descending classification illustrated by a dendrogram
|
Day 0
|
|
Describe the predominant lexical classes in participants' discourse
Time Frame: Day 0
|
Description of lexical classes and forms associated with the classes
|
Day 0
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Identify links between work organization, environment and personal working time during atypical working hours
Time Frame: Day 0
|
Forms associated with atypical working hours
|
Day 0
|
|
To identify links between work organization, environment and personal working time during periods of inactivity at work
Time Frame: Day 0
|
Forms associated with periods of inactivity at work
|
Day 0
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Atypical working hours pattern
Time Frame: Day 0
|
If yes, type of atypical work schedule
|
Day 0
|
|
Amount of inactivity time at work
Time Frame: Day 0
|
Cumulative duration for the past 5 days (minutes)
|
Day 0
|
|
Proportion of gambling practices
Time Frame: Day 0
|
From exclusively in-person to exclusively online
|
Day 0
|
|
At-risk gambling
Time Frame: Day 0
|
Assessed using the French version of the Problem Gambling Index Scale (PGSI) scale using cut-off ≥5
|
Day 0
|
|
Perceived prevalence of betting by colleagues
Time Frame: Day 0
|
Measured on custom tool combining items from two existing questionnaires: Gambling Quantity and Perceived Norms Scale (GQPNS); Gambling Attitudes and Injunctive Norms Scale (GAINS)
|
Day 0
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Amandine Luquiens, Centre Hospitalier Universitaire de Nīmes
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
February 5, 2026
Primary Completion (Estimated)
February 1, 2027
Study Completion (Estimated)
February 1, 2027
Study Registration Dates
First Submitted
February 9, 2026
First Submitted That Met QC Criteria
February 17, 2026
First Posted (Actual)
February 19, 2026
Study Record Updates
Last Update Posted (Actual)
February 19, 2026
Last Update Submitted That Met QC Criteria
February 17, 2026
Last Verified
February 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RESP/PRAT-JEU/2025/AL-01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Addictive Behavior
-
UConn HealthNational Institute on Drug Abuse (NIDA)CompletedExercise | Addictive BehaviorsUnited States
-
Centre Hospitalier Charles Perrens, BordeauxRecruitingAddiction | Addictive Behaviors | Addiction DisordersFrance
-
Northern Jiangsu People's HospitalCompletedPropofol | Addictive BehaviorsChina
-
Assiut UniversityNot yet recruitingAddictive Behavior | Adolescent BehaviorEgypt
-
National Institute on Drug Abuse (NIDA)Terminated
-
Centre Hospitalier Henri LaboritNot yet recruitingDependence Addictive
-
Marmara UniversityCompleted
-
University of MiamiCompleted
-
Federal University of São PauloFundação de Amparo à Pesquisa do Estado de São Paulo; Conselho Nacional de... and other collaboratorsCompletedAddictive Behavior | Abstinence SyndromeBrazil
-
Martha TillsonNational Institute on Drug Abuse (NIDA)Not yet recruiting
Clinical Trials on semi-structured interview
-
University Hospital, GrenobleNot yet recruiting
-
University Hospital, AntwerpRecruitingAnxiety | Elective Surgery | Chronic Post Surgical PainBelgium
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Multiple Sclerosis | Parkinson Disease | Rehabilitation | Neurologic Disorder | NeurosurgeryItaly
-
Assistance Publique - Hôpitaux de ParisURC Necker Cochin, FranceCompleted
-
Hospices Civils de LyonCompleted
-
University of OxfordCompletedCeliac Disease | Mental Health Wellness 1 | Emotional Problem | Stigma, Social | Celiac Disease in Children | Celiac | DisclosureUnited Kingdom
-
University Hospital, BordeauxCompleted
-
St Vincent's Hospital, SydneyUniversity of Technology, SydneyRecruitingProstate Cancer (Adenocarcinoma)Australia
-
University Hospital, Clermont-FerrandResearch on Healthcare Performance Lab U1290RecruitingJuvenile Idiopathic ArthritisFrance
-
Medstar Health Research InstituteActive, not recruitingUrinary Tract Infections | Spinal Cord Injuries | Urinary Retention | Neurogenic BladderUnited States